Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel A Behr

Showing results (171-180 of 209) with videos related to

Pageof 21
Sort By:
Plos Pathogens|June 19, 2018
RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protectionLouis S Ates, Fadel Sayes, Wafa Frigui, et al.
Mbio|October 21, 2020
Heterologous Production of 1-Tuberculosinyladenosine in Mycobacterium kansasii Models Pathoevolution towards the Transcellular Lifestyle of Mycobacterium tuberculosisMarwan Ghanem, Jean-Yves Dubé, Joyce Wang, et al.
The Journal of Experimental Medicine|July 8, 2009
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptideFrançois Coulombe, Maziar Divangahi, Frédéric Veyrier, et al.
Infection Control and Hospital Epidemiology|December 16, 2020
Evaluation of a home-based 7-day infection control strategy for healthcare workers following high-risk exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2): A cohort studyCarla Benea, Laura Rendon, Jesse Papenburg, et al.
The Lancet. Respiratory Medicine|January 25, 2024
What is next for BCG revaccination to prevent tuberculosis?Richard G White, Andrew J Fiore-Gartland, Willem A Hanekom, et al.
International Journal of Epidemiology|April 15, 2004
Transmission of tuberculosis in a high incidence urban community in South AfricaSuzanne Verver, Robin M Warren, Zahn Munch, et al.
Thorax|January 29, 2024
Challenging the gold standard: the limitations of molecular assays for detection of <i>Mycobacterium tuberculosis</i> heteroresistanceSarah N Danchuk, Ori E Solomon, Thomas Andreas Kohl, et al.
Frontiers in Microbiology|December 13, 2018
A New Phylogenetic Framework for the Animal-Adapted <i>Mycobacterium tuberculosis</i> ComplexDaniela Brites, Chloé Loiseau, Fabrizio Menardo, et al.
The Journal of Infectious Diseases|August 22, 2023
An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine TrialsPhilip C Hill, Frank Cobelens, Leonardo Martinez, et al.
The Journal of Infectious Diseases|November 23, 2013
N-glycolylated peptidoglycan contributes to the immunogenicity but not pathogenicity of Mycobacterium tuberculosisJesse M Hansen, Solmaz A Golchin, Frédéric J Veyrier, et al.
Pageof 21

Showing results (171-180 of 209) with videos related to

Sort By:
Pageof 21
Plos Pathogens|June 19, 2018
RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protectionLouis S Ates, Fadel Sayes, Wafa Frigui, et al.
Mbio|October 21, 2020
Heterologous Production of 1-Tuberculosinyladenosine in Mycobacterium kansasii Models Pathoevolution towards the Transcellular Lifestyle of Mycobacterium tuberculosisMarwan Ghanem, Jean-Yves Dubé, Joyce Wang, et al.
The Journal of Experimental Medicine|July 8, 2009
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptideFrançois Coulombe, Maziar Divangahi, Frédéric Veyrier, et al.
Infection Control and Hospital Epidemiology|December 16, 2020
Evaluation of a home-based 7-day infection control strategy for healthcare workers following high-risk exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2): A cohort studyCarla Benea, Laura Rendon, Jesse Papenburg, et al.
The Lancet. Respiratory Medicine|January 25, 2024
What is next for BCG revaccination to prevent tuberculosis?Richard G White, Andrew J Fiore-Gartland, Willem A Hanekom, et al.
International Journal of Epidemiology|April 15, 2004
Transmission of tuberculosis in a high incidence urban community in South AfricaSuzanne Verver, Robin M Warren, Zahn Munch, et al.
Thorax|January 29, 2024
Challenging the gold standard: the limitations of molecular assays for detection of <i>Mycobacterium tuberculosis</i> heteroresistanceSarah N Danchuk, Ori E Solomon, Thomas Andreas Kohl, et al.
Frontiers in Microbiology|December 13, 2018
A New Phylogenetic Framework for the Animal-Adapted <i>Mycobacterium tuberculosis</i> ComplexDaniela Brites, Chloé Loiseau, Fabrizio Menardo, et al.
The Journal of Infectious Diseases|August 22, 2023
An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine TrialsPhilip C Hill, Frank Cobelens, Leonardo Martinez, et al.
The Journal of Infectious Diseases|November 23, 2013
N-glycolylated peptidoglycan contributes to the immunogenicity but not pathogenicity of Mycobacterium tuberculosisJesse M Hansen, Solmaz A Golchin, Frédéric J Veyrier, et al.
Pageof 21